Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-10 | Amended | $2,340,326 | $749,997 | Equity Only | 06b | SEC link |
| 2024-10-03 | Amended | $1,590,329 | $640,329 | Equity Only | 06b | SEC link |
| 2024-09-27 | New | $950,000 | $950,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Michael Freeman | Director |
| Jason Grimes | Director |
| Stephen Hoag | Director |
| Jeremy Starkweather | Director, Executive |
| John Wynne | Director, Executive |
| Jason Ylizarde | Executive |